Oxford Biomedica Regulatory News (OXB)

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Oxford Biomedica PLC

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

Oaktree Capital Group Holdings GP, LLC

City and country of registered office (if applicable)

333 South Grand Ave., 28th Floor Los Angeles, CA 90071, U.S.A.

4. Full name of shareholder(s) (if different from 3.)v

Name

OCM Strategic Credit Investments S.A R.L.

Name

OCM Strategic Credit Investments 2 S.A R.L.

Name

OCM Luxembourg SC Fund A S.A R.L.

Name

OCM Luxembourg SC Fund B S.A R.L.

City and country of registered office (if applicable)

26A boulevard Royal, 7th Floor, L-2449Luxembourg

5. Date on which the threshold was crossed or reachedvi:

26 April 2019

6. Date on which issuer notified (DD/MM/YYYY):

30 April 2019

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

3.91%

N/A

3.91%

68,860,324

Position of previous notification (if

applicable)

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Ordinary shares

0

2,689,686

0.00%

3.91%

SUBTOTAL 8. A

2,689,686

3.91%

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

N/A

N/A

N/A

N/A

N/A

SUBTOTAL 8. B 1

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

N/A

N/A

N/A

N/A

N/A

N/A

SUBTOTAL 8.B.2

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

X

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Oaktree Capital Group Holdings GP, LLC

Oaktree Capital Group, LLC

Oaktree Holdings, Inc.

Oaktree CapitalManagement, L.P.

Oaktree-TCDRSStrategic Credit, LLC

Oaktree-TSE 16Strategic Credit, LLC

Oaktree StrategicIncome, LLC

INPRS Strategic Credit Holdings, LLC

OCM Strategic Credit Investments S.A R.L.[1]

1.103%

Oaktree Capital Group Holdings GP, LLC

Oaktree Capital Group, LLC

Oaktree Holdings, Inc.

Oaktree CapitalManagement, L.P.

Exelon Strategic Credit Holdings, LLC

Oaktree-NGP Strategic Credit, LLC

Oaktree-Minn Strategic Credit, LLC

Oaktree-ForestMulti-Strategy, LLC (Series A)

Oaktree-TBMR Strategic Credit Fund C, LLC

Oaktree-TBMR Strategic Credit Fund F, LLC

Oaktree-TBMR Strategic Credit Fund G, LLC

OCM Strategic Credit Investments 2 S.A R.L.[2]

2.065%

Oaktree Capital Group Holdings GP, LLC

Oaktree Capital Group, LLC

Oaktree Holdings, Inc.

Oaktree CapitalManagement, L.P.

Oaktree Capital II, L.P.

Oaktree Fund GP II, L.P.

Oaktree Fund GP IIA, LLC

Oaktree Strategic Credit Fund A GP, L.P.

Oaktree Strategic Credit Fund A, L.P.

OCM Luxembourg SC Fund A S.A R.L.

0.164%

Oaktree Capital Group Holdings GP, LLC

Oaktree Capital Group, LLC

Oaktree Holdings, Inc.

Oaktree Capital Management, L.P.

Oaktree Capital II, L.P.

Oaktree Fund GP II, L.P.

Oaktree Fund GP IIA, LLC

Oaktree Strategic Credit Fund B GP, L.P.

Oaktree Strategic Credit Fund B, L.P.

OCM Luxembourg SC Fund B SP 1, L.P.

OCM Luxembourg SC Fund B S.A R.L.

0.572%

10. In case of proxy voting, please identify:

Name of the proxy holder

N/A

The number and % of voting rights held

N/A

The date until which the voting rights will be held

N/A

11. Additional information

Place of completion

London, United Kingdom

Date of completion

30 April 2019

Contact name:

Stuart Paynter

Contact telephone number:

01865 783000